276 related articles for article (PubMed ID: 32815286)
1. Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: A systematic review and meta-analysis.
Buawangpong N; Teekachunhatean S; Koonrungsesomboon N
Pharmacol Res Perspect; 2020 Oct; 8(5):e00644. PubMed ID: 32815286
[TBL] [Abstract][Full Text] [Related]
2. Is there an embryopathy associated with first-trimester exposure to angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists? A critical review of the evidence.
Polifka JE
Birth Defects Res A Clin Mol Teratol; 2012 Aug; 94(8):576-98. PubMed ID: 22807387
[TBL] [Abstract][Full Text] [Related]
3. Maternal and perinatal outcomes associated with the use of renin-angiotensin system (RAS) blockers for chronic hypertension in early pregnancy.
Ahmed B; Tran DT; Zoega H; Kennedy SE; Jorm LR; Havard A
Pregnancy Hypertens; 2018 Oct; 14():156-161. PubMed ID: 30527105
[TBL] [Abstract][Full Text] [Related]
4. Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis.
Fu J; Tomlinson G; Feig DS
Diabetes Metab Res Rev; 2021 Nov; 37(8):e3453. PubMed ID: 33779043
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in women of childbearing age: risks versus benefits.
Pucci M; Sarween N; Knox E; Lipkin G; Martin U
Expert Rev Clin Pharmacol; 2015 Mar; 8(2):221-31. PubMed ID: 25612630
[TBL] [Abstract][Full Text] [Related]
6. ACE Inhibitor Benefit to Kidney and Cardiovascular Outcomes for Patients with Non-Dialysis Chronic Kidney Disease Stages 3-5: A Network Meta-Analysis of Randomised Clinical Trials.
Zhang Y; He D; Zhang W; Xing Y; Guo Y; Wang F; Jia J; Yan T; Liu Y; Lin S
Drugs; 2020 Jun; 80(8):797-811. PubMed ID: 32333236
[TBL] [Abstract][Full Text] [Related]
7. A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?
Kurdi A; Abutheraa N; Akil L; Godman B
Pharmacol Res Perspect; 2020 Dec; 8(6):e00666. PubMed ID: 33084232
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors/angiotensin receptor blockers therapy and colorectal cancer: a systematic review and meta-analysis.
Dai YN; Wang JH; Zhu JZ; Lin JQ; Yu CH; Li YM
Cancer Causes Control; 2015 Sep; 26(9):1245-55. PubMed ID: 26081426
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in diabetic nephropathy: a systematic review and meta-analysis.
Du YH; Guan CJ; Li LY; Gan P
Ann Palliat Med; 2022 Mar; 11(3):1093-1101. PubMed ID: 35365039
[TBL] [Abstract][Full Text] [Related]
10. The divergent protective effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on clinical outcomes of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
Xie Q; Tang S; Li Y
Ann Palliat Med; 2022 Apr; 11(4):1253-1263. PubMed ID: 34775774
[TBL] [Abstract][Full Text] [Related]
11. Association Between Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in Patients With COVID-19: A Systematic Review and Meta-analysis.
Baral R; Tsampasian V; Debski M; Moran B; Garg P; Clark A; Vassiliou VS
JAMA Netw Open; 2021 Mar; 4(3):e213594. PubMed ID: 33787911
[TBL] [Abstract][Full Text] [Related]
12. Increased rate of birth defects after first trimester use of angiotensin converting enzyme inhibitors - Treatment or hypertension related? An observational cohort study.
Hoeltzenbein M; Tissen-Diabaté T; Fietz AK; Zinke S; Kayser A; Meister R; Weber-Schoendorfer C; Schaefer C
Pregnancy Hypertens; 2018 Jul; 13():65-71. PubMed ID: 30177074
[TBL] [Abstract][Full Text] [Related]
13. Association Between Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, and Suicide.
Mamdani M; Gomes T; Greaves S; Manji S; Juurlink DN; Tadrous M; Kennedy SH; Antoniou T
JAMA Netw Open; 2019 Oct; 2(10):e1913304. PubMed ID: 31617924
[TBL] [Abstract][Full Text] [Related]
14. A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
Grover A; Oberoi M
Eur Heart J Cardiovasc Pharmacother; 2021 Mar; 7(2):148-157. PubMed ID: 32542337
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome after first trimester use of angiotensin AT1 receptor blockers: an observational cohort study.
Hoeltzenbein M; Tissen-Diabaté T; Fietz AK; Zinke S; Kayser A; Meister R; Weber-Schoendorfer C; Schaefer C
Clin Res Cardiol; 2018 Aug; 107(8):679-687. PubMed ID: 29574489
[TBL] [Abstract][Full Text] [Related]
16. Adverse perinatal outcomes associated with prenatal exposure to protease-inhibitor-based versus non-nucleoside reverse transcriptase inhibitor-based antiretroviral combinations in pregnant women with HIV infection: a systematic review and meta-analysis.
Saint-Lary L; Benevent J; Damase-Michel C; Vayssière C; Leroy V; Sommet A
BMC Pregnancy Childbirth; 2023 Jan; 23(1):80. PubMed ID: 36717801
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy outcomes following first-trimester exposure to topical retinoids: a systematic review and meta-analysis.
Kaplan YC; Ozsarfati J; Etwel F; Nickel C; Nulman I; Koren G
Br J Dermatol; 2015 Nov; 173(5):1132-41. PubMed ID: 26215715
[TBL] [Abstract][Full Text] [Related]
18. Higher versus lower doses of ACE inhibitors, angiotensin-2 receptor blockers and beta-blockers in heart failure with reduced ejection fraction: Systematic review and meta-analysis.
Turgeon RD; Kolber MR; Loewen P; Ellis U; McCormack JP
PLoS One; 2019; 14(2):e0212907. PubMed ID: 30817783
[TBL] [Abstract][Full Text] [Related]
19. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
Diav-Citrin O; Shechtman S; Halberstadt Y; Finkel-Pekarsky V; Wajnberg R; Arnon J; Di Gianantonio E; Clementi M; Ornoy A
Reprod Toxicol; 2011 May; 31(4):540-5. PubMed ID: 21338666
[TBL] [Abstract][Full Text] [Related]
20. Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis.
Cheng J; Zhang W; Zhang X; Han F; Li X; He X; Li Q; Chen J
JAMA Intern Med; 2014 May; 174(5):773-85. PubMed ID: 24687000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
